2026 continues to gain momentum with strategic acquisitions and funding rounds driving growth across surgical robotics, AI diagnostics, and next-generation therapeutic devices. Capital is flowing to support commercialization, clinical expansion, and innovation that is...
2026 continues to gain momentum with strategic acquisitions and funding rounds driving growth across surgical robotics, AI diagnostics, and next-generation therapeutic devices. Capital is...
Melbourne-based respiratory imaging company 4DMedical has raised $150 million from institutional investors to accelerate commercialisation of its key CT:VQ product in the US where...
Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech giant’s offerings in ‘fast-growing...
Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.
The St. Louis-based company also picked up Category B assignment...
Heart Failure Solutions, a clinical-stage medtech company based outside Minneapolis, announced the first successful in-human use of its PeriCut system, designed to treat patients...
JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system.
Results from the ALIGN-AR pivotal...
Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...
Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform.
Ivy integrates advanced imaging, AI and robotic...
2026 continues to gain momentum with strategic acquisitions and funding rounds driving growth across surgical robotics, AI diagnostics, and next-generation therapeutic devices. Capital is...
Melbourne-based respiratory imaging company 4DMedical has raised $150 million from institutional investors to accelerate commercialisation of its key CT:VQ product in the US where...
Boston Scientific has agreed to acquire Penumbra in a deal worth around $14.5bn, a move that will expand the medtech giant’s offerings in ‘fast-growing...
Amplifi Vascular announced that it received breakthrough device designation for its Amplifi Vein Dilation System.
The St. Louis-based company also picked up Category B assignment...